The Q Cap device enables needle-free reconstitution for fertility treatments. The device will be packaged with Bravelle (urofollitropin for injection, purified). For more information about this product, contact Ferring Pharmaceuticals Inc. by calling 888-337-7464 or visiting www.ferringusa.com.
COPYRIGHT 2005 International Medical News Group
COPYRIGHT 2005 Gale Group
Contact
Home
A
Ubidecarenone